Jerry Ware
Concepts (428)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Platelets | 52 | 2023 | 269 | 7.510 |
Why?
| Platelet Glycoprotein GPIb-IX Complex | 36 | 2022 | 53 | 4.910 |
Why?
| Thrombosis | 16 | 2023 | 243 | 2.940 |
Why?
| Hemostasis | 14 | 2020 | 57 | 2.830 |
Why?
| von Willebrand Factor | 15 | 2022 | 54 | 2.300 |
Why?
| Platelet Membrane Glycoproteins | 14 | 2018 | 25 | 1.990 |
Why?
| Cell-Derived Microparticles | 6 | 2018 | 21 | 1.820 |
Why?
| Platelet Activation | 14 | 2020 | 49 | 1.790 |
Why?
| Bernard-Soulier Syndrome | 6 | 2022 | 6 | 1.540 |
Why?
| Sepsis | 4 | 2018 | 253 | 1.460 |
Why?
| von Willebrand Diseases | 5 | 2016 | 21 | 1.290 |
Why?
| Animals | 69 | 2022 | 14435 | 1.130 |
Why?
| Thrombin | 7 | 2016 | 50 | 1.010 |
Why?
| Neoplasms | 4 | 2019 | 1309 | 1.000 |
Why?
| Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2013 | 34 | 0.990 |
Why?
| Inflammation | 6 | 2023 | 677 | 0.990 |
Why?
| Cell Cycle Proteins | 6 | 2006 | 198 | 0.980 |
Why?
| Mice | 48 | 2022 | 6436 | 0.980 |
Why?
| Platelet Aggregation | 14 | 2023 | 82 | 0.940 |
Why?
| Hemorrhage | 7 | 2018 | 204 | 0.910 |
Why?
| Thrombocytopenia | 8 | 2019 | 98 | 0.900 |
Why?
| Mice, Knockout | 24 | 2020 | 941 | 0.880 |
Why?
| Carcinoma, Lewis Lung | 2 | 2012 | 11 | 0.800 |
Why?
| Melanoma, Experimental | 2 | 2012 | 49 | 0.770 |
Why?
| Mice, Inbred C57BL | 24 | 2021 | 2021 | 0.700 |
Why?
| Klebsiella Infections | 2 | 2018 | 12 | 0.680 |
Why?
| Klebsiella pneumoniae | 2 | 2018 | 23 | 0.680 |
Why?
| Pneumonia, Bacterial | 2 | 2018 | 26 | 0.680 |
Why?
| Phosphatidylserines | 1 | 2018 | 4 | 0.680 |
Why?
| Signal Transduction | 12 | 2018 | 1754 | 0.670 |
Why?
| Disease Models, Animal | 17 | 2022 | 1645 | 0.660 |
Why?
| Mice, Transgenic | 22 | 2019 | 662 | 0.660 |
Why?
| Haplotypes | 1 | 2018 | 105 | 0.660 |
Why?
| Phenotype | 10 | 2018 | 822 | 0.620 |
Why?
| Receptors, Proteinase-Activated | 3 | 2016 | 5 | 0.620 |
Why?
| Megakaryocytes | 6 | 2017 | 23 | 0.610 |
Why?
| Cytoskeletal Proteins | 5 | 2006 | 58 | 0.600 |
Why?
| Hemorrhagic Disorders | 2 | 2013 | 6 | 0.580 |
Why?
| GTP Phosphohydrolases | 4 | 2004 | 35 | 0.570 |
Why?
| Blood Platelet Disorders | 3 | 2016 | 8 | 0.560 |
Why?
| GTP-Binding Proteins | 3 | 2006 | 95 | 0.540 |
Why?
| Humans | 58 | 2023 | 54132 | 0.540 |
Why?
| Point Mutation | 2 | 2013 | 93 | 0.530 |
Why?
| Renal Insufficiency, Chronic | 3 | 2023 | 183 | 0.510 |
Why?
| von Willebrand Disease, Type 2 | 1 | 2013 | 2 | 0.490 |
Why?
| Amino Acid Substitution | 1 | 2013 | 106 | 0.480 |
Why?
| Platelet Transfusion | 6 | 2020 | 32 | 0.460 |
Why?
| Mutation, Missense | 1 | 2013 | 117 | 0.460 |
Why?
| RNA Splicing | 1 | 2013 | 38 | 0.460 |
Why?
| Cell Lineage | 1 | 2013 | 94 | 0.450 |
Why?
| Blood Preservation | 3 | 2020 | 29 | 0.450 |
Why?
| Communicable Diseases | 1 | 2013 | 55 | 0.450 |
Why?
| Protein Binding | 12 | 2021 | 743 | 0.440 |
Why?
| Single-Chain Antibodies | 1 | 2012 | 28 | 0.430 |
Why?
| Endothelium, Vascular | 3 | 2013 | 293 | 0.430 |
Why?
| Lung Neoplasms | 2 | 2009 | 631 | 0.430 |
Why?
| Tumor Microenvironment | 1 | 2012 | 207 | 0.400 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 239 | 0.380 |
Why?
| Blood Coagulation | 5 | 2018 | 70 | 0.380 |
Why?
| Platelet Adhesiveness | 5 | 2013 | 13 | 0.380 |
Why?
| Neutrophils | 4 | 2018 | 156 | 0.370 |
Why?
| Collagen | 7 | 2016 | 229 | 0.370 |
Why?
| Neoplastic Cells, Circulating | 1 | 2010 | 93 | 0.360 |
Why?
| Cold Temperature | 2 | 2020 | 54 | 0.350 |
Why?
| Gene Deletion | 3 | 2007 | 296 | 0.340 |
Why?
| Septins | 7 | 2006 | 19 | 0.340 |
Why?
| Venous Thrombosis | 3 | 2018 | 102 | 0.340 |
Why?
| Mutation | 4 | 2016 | 1499 | 0.320 |
Why?
| Membrane Glycoproteins | 4 | 2013 | 269 | 0.320 |
Why?
| Blood Vessels | 2 | 2020 | 79 | 0.290 |
Why?
| Bleeding Time | 5 | 2014 | 11 | 0.290 |
Why?
| Tubulin | 1 | 2006 | 28 | 0.290 |
Why?
| Microtubules | 1 | 2006 | 57 | 0.280 |
Why?
| Membrane Proteins | 3 | 2004 | 391 | 0.260 |
Why?
| Vena Cava, Inferior | 2 | 2018 | 78 | 0.260 |
Why?
| Immunoglobulins, Intravenous | 2 | 2017 | 55 | 0.250 |
Why?
| Blood Proteins | 2 | 2018 | 101 | 0.250 |
Why?
| Monocytes | 3 | 2018 | 156 | 0.250 |
Why?
| Ligands | 4 | 2014 | 233 | 0.240 |
Why?
| Male | 18 | 2023 | 27350 | 0.240 |
Why?
| Bone and Bones | 1 | 2008 | 523 | 0.240 |
Why?
| Nerve Tissue Proteins | 2 | 2002 | 196 | 0.230 |
Why?
| Tumor Escape | 2 | 2015 | 21 | 0.230 |
Why?
| Flow Cytometry | 5 | 2013 | 548 | 0.230 |
Why?
| Neovascularization, Pathologic | 3 | 2015 | 172 | 0.230 |
Why?
| Female | 16 | 2023 | 28437 | 0.220 |
Why?
| Cell Communication | 2 | 2014 | 70 | 0.220 |
Why?
| Integrins | 2 | 2020 | 36 | 0.220 |
Why?
| Neoplasm Invasiveness | 2 | 2015 | 294 | 0.210 |
Why?
| Homeostasis | 2 | 2020 | 223 | 0.210 |
Why?
| Thrombopoiesis | 3 | 2011 | 8 | 0.210 |
Why?
| Antibodies, Monoclonal | 5 | 2017 | 560 | 0.210 |
Why?
| Radiation Protection | 1 | 2021 | 56 | 0.200 |
Why?
| Time Factors | 7 | 2020 | 3223 | 0.200 |
Why?
| Calcium | 3 | 2020 | 434 | 0.200 |
Why?
| Platelet Aggregation Inhibitors | 4 | 2023 | 180 | 0.200 |
Why?
| Egtazic Acid | 1 | 2020 | 17 | 0.200 |
Why?
| Tail | 3 | 2014 | 10 | 0.190 |
Why?
| Arthritis, Experimental | 2 | 2017 | 10 | 0.180 |
Why?
| Severity of Illness Index | 2 | 2018 | 1084 | 0.180 |
Why?
| Synovial Membrane | 2 | 2017 | 17 | 0.180 |
Why?
| Sertraline | 1 | 2019 | 47 | 0.180 |
Why?
| Case-Control Studies | 2 | 2023 | 1242 | 0.180 |
Why?
| Protein Structure, Tertiary | 5 | 2013 | 289 | 0.180 |
Why?
| Melioidosis | 1 | 2019 | 5 | 0.170 |
Why?
| Burkholderia pseudomallei | 1 | 2019 | 9 | 0.170 |
Why?
| Proto-Oncogene Proteins c-kit | 2 | 2017 | 35 | 0.170 |
Why?
| Gray Platelet Syndrome | 1 | 2018 | 1 | 0.170 |
Why?
| Cell Proliferation | 2 | 2015 | 1099 | 0.170 |
Why?
| Age of Onset | 1 | 2018 | 116 | 0.170 |
Why?
| Thrombopoietin | 1 | 2018 | 10 | 0.170 |
Why?
| Multiple Organ Failure | 1 | 2018 | 56 | 0.160 |
Why?
| Platelet Count | 4 | 2023 | 77 | 0.160 |
Why?
| src-Family Kinases | 2 | 2009 | 54 | 0.160 |
Why?
| Genetic Predisposition to Disease | 2 | 2018 | 575 | 0.160 |
Why?
| Immunoglobulin Fc Fragments | 1 | 2017 | 13 | 0.160 |
Why?
| Refrigeration | 1 | 2017 | 4 | 0.160 |
Why?
| Genetic Association Studies | 1 | 2018 | 140 | 0.160 |
Why?
| Depressive Disorder, Major | 1 | 2019 | 157 | 0.160 |
Why?
| Cell Differentiation | 3 | 2011 | 717 | 0.160 |
Why?
| rhoA GTP-Binding Protein | 1 | 2017 | 8 | 0.160 |
Why?
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 25 | 0.160 |
Why?
| cdc42 GTP-Binding Protein | 1 | 2017 | 11 | 0.160 |
Why?
| Mechanotransduction, Cellular | 1 | 2017 | 35 | 0.150 |
Why?
| Cell Line, Tumor | 3 | 2018 | 1542 | 0.150 |
Why?
| Glycosphingolipids | 1 | 2016 | 3 | 0.150 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2016 | 21 | 0.150 |
Why?
| Membrane Microdomains | 1 | 2016 | 15 | 0.140 |
Why?
| Receptors, Purinergic P2 | 2 | 2009 | 37 | 0.140 |
Why?
| Recombinant Proteins | 6 | 2018 | 574 | 0.140 |
Why?
| Microfilament Proteins | 2 | 2016 | 47 | 0.140 |
Why?
| Plaque, Atherosclerotic | 1 | 2016 | 47 | 0.140 |
Why?
| Lentivirus | 2 | 2014 | 18 | 0.140 |
Why?
| Disease Progression | 1 | 2018 | 915 | 0.140 |
Why?
| Lectins, C-Type | 3 | 2020 | 32 | 0.130 |
Why?
| Anticarcinogenic Agents | 1 | 2015 | 35 | 0.130 |
Why?
| Carotid Artery Thrombosis | 1 | 2014 | 4 | 0.130 |
Why?
| Liver | 2 | 2019 | 1246 | 0.130 |
Why?
| Amino Acid Sequence | 3 | 2013 | 777 | 0.130 |
Why?
| Phosphorylation | 4 | 2006 | 609 | 0.130 |
Why?
| Liver Neoplasms | 1 | 2019 | 353 | 0.130 |
Why?
| Pancreatic Neoplasms | 1 | 2018 | 235 | 0.130 |
Why?
| Genetic Therapy | 2 | 2014 | 121 | 0.130 |
Why?
| Busulfan | 1 | 2014 | 18 | 0.130 |
Why?
| Molecular Sequence Data | 3 | 2013 | 996 | 0.130 |
Why?
| Neoplasm Metastasis | 1 | 2015 | 252 | 0.130 |
Why?
| Cell Death | 1 | 2015 | 228 | 0.120 |
Why?
| Neovascularization, Physiologic | 1 | 2014 | 75 | 0.120 |
Why?
| Macrophage-1 Antigen | 1 | 2014 | 8 | 0.120 |
Why?
| Neoplastic Stem Cells | 1 | 2015 | 103 | 0.120 |
Why?
| Collagen Type IV | 1 | 2013 | 14 | 0.120 |
Why?
| Mice, 129 Strain | 1 | 2014 | 49 | 0.120 |
Why?
| Ligation | 1 | 2014 | 66 | 0.120 |
Why?
| Interleukin-4 | 1 | 2014 | 48 | 0.120 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2013 | 9 | 0.120 |
Why?
| Transplantation Conditioning | 1 | 2014 | 86 | 0.120 |
Why?
| Aspirin | 1 | 2015 | 127 | 0.120 |
Why?
| Dermatitis, Contact | 1 | 2013 | 2 | 0.120 |
Why?
| Cecum | 1 | 2014 | 72 | 0.120 |
Why?
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2013 | 3 | 0.120 |
Why?
| Antibodies, Blocking | 1 | 2013 | 8 | 0.120 |
Why?
| Immune Complex Diseases | 1 | 2013 | 9 | 0.120 |
Why?
| Fibrinogen | 3 | 2009 | 37 | 0.120 |
Why?
| Endotoxemia | 1 | 2013 | 31 | 0.120 |
Why?
| Adenocarcinoma | 1 | 2018 | 428 | 0.120 |
Why?
| Atherosclerosis | 1 | 2016 | 253 | 0.110 |
Why?
| DNA-Binding Proteins | 1 | 2016 | 463 | 0.110 |
Why?
| Platelet Membrane Glycoprotein IIb | 2 | 2009 | 6 | 0.110 |
Why?
| Cell Membrane | 4 | 2012 | 279 | 0.110 |
Why?
| Contractile Proteins | 1 | 2011 | 5 | 0.110 |
Why?
| Histocompatibility, Maternal-Fetal | 1 | 2011 | 1 | 0.110 |
Why?
| Cytokines | 2 | 2019 | 678 | 0.110 |
Why?
| Receptors, Fc | 1 | 2011 | 9 | 0.110 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 51 | 0.100 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 436 | 0.100 |
Why?
| Abortion, Spontaneous | 1 | 2011 | 22 | 0.100 |
Why?
| Cyclooxygenase 1 | 1 | 2011 | 6 | 0.100 |
Why?
| Models, Biological | 1 | 2015 | 824 | 0.100 |
Why?
| Epoprostenol | 1 | 2011 | 27 | 0.100 |
Why?
| Synovitis | 1 | 2011 | 24 | 0.100 |
Why?
| Genetic Vectors | 1 | 2011 | 136 | 0.100 |
Why?
| Infant, Newborn | 1 | 2018 | 2901 | 0.100 |
Why?
| Plateletpheresis | 1 | 2010 | 8 | 0.100 |
Why?
| Genotype | 3 | 2017 | 607 | 0.100 |
Why?
| Serotonin | 1 | 2012 | 158 | 0.100 |
Why?
| Peptides | 3 | 2018 | 278 | 0.100 |
Why?
| P-Selectin | 3 | 2019 | 33 | 0.100 |
Why?
| Bone Marrow Cells | 2 | 2009 | 234 | 0.100 |
Why?
| Down-Regulation | 1 | 2012 | 392 | 0.090 |
Why?
| Tumor Burden | 1 | 2010 | 142 | 0.090 |
Why?
| Synovial Fluid | 1 | 2010 | 18 | 0.090 |
Why?
| Killer Cells, Natural | 1 | 2010 | 107 | 0.090 |
Why?
| Adolescent | 2 | 2019 | 6890 | 0.090 |
Why?
| Anaphylaxis | 1 | 2010 | 71 | 0.090 |
Why?
| Infant | 1 | 2018 | 3797 | 0.090 |
Why?
| Carotid Artery Injuries | 1 | 2009 | 14 | 0.090 |
Why?
| Child, Preschool | 1 | 2018 | 4132 | 0.090 |
Why?
| Transplantation, Isogeneic | 1 | 2009 | 2 | 0.090 |
Why?
| Risk Factors | 1 | 2018 | 3936 | 0.090 |
Why?
| Crosses, Genetic | 1 | 2009 | 32 | 0.090 |
Why?
| Immunoprecipitation | 2 | 2011 | 73 | 0.090 |
Why?
| Microscopy, Confocal | 1 | 2009 | 110 | 0.090 |
Why?
| Recombinant Fusion Proteins | 2 | 2013 | 206 | 0.090 |
Why?
| Haploidy | 1 | 2009 | 5 | 0.090 |
Why?
| Injections, Intravenous | 1 | 2009 | 148 | 0.090 |
Why?
| Protein Transport | 2 | 2011 | 196 | 0.090 |
Why?
| Arthritis, Rheumatoid | 1 | 2010 | 129 | 0.080 |
Why?
| Protein Conformation | 3 | 2017 | 227 | 0.080 |
Why?
| Embryonic Stem Cells | 1 | 2008 | 17 | 0.080 |
Why?
| Metalloproteases | 1 | 2008 | 10 | 0.080 |
Why?
| Receptors, Collagen | 2 | 2010 | 3 | 0.080 |
Why?
| Cells, Cultured | 5 | 2018 | 1755 | 0.080 |
Why?
| Splenomegaly | 1 | 2008 | 16 | 0.080 |
Why?
| Chromosomes | 1 | 2007 | 37 | 0.080 |
Why?
| Protein Structure, Secondary | 1 | 2008 | 99 | 0.080 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2013 | 150 | 0.080 |
Why?
| Protein Subunits | 1 | 2007 | 86 | 0.070 |
Why?
| Hepatocytes | 2 | 2019 | 216 | 0.070 |
Why?
| Nocodazole | 1 | 2006 | 9 | 0.070 |
Why?
| Receptors, IgG | 2 | 2003 | 22 | 0.070 |
Why?
| Neoplasm Proteins | 1 | 2009 | 367 | 0.070 |
Why?
| Cell Adhesion Molecules | 1 | 2006 | 87 | 0.070 |
Why?
| Tubulin Modulators | 1 | 2006 | 40 | 0.070 |
Why?
| Apoptosis | 2 | 2020 | 1306 | 0.070 |
Why?
| Protein-Tyrosine Kinases | 1 | 2006 | 100 | 0.070 |
Why?
| Bone Marrow | 2 | 2011 | 415 | 0.070 |
Why?
| Child | 1 | 2018 | 7312 | 0.070 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 153 | 0.070 |
Why?
| Thromboplastin | 2 | 2018 | 9 | 0.070 |
Why?
| Collagen Type I | 1 | 2006 | 98 | 0.070 |
Why?
| Structure-Activity Relationship | 2 | 2017 | 428 | 0.070 |
Why?
| Adenosine Triphosphate | 1 | 2006 | 253 | 0.060 |
Why?
| Consensus Sequence | 1 | 2004 | 25 | 0.060 |
Why?
| Ploidies | 1 | 2004 | 13 | 0.060 |
Why?
| COS Cells | 1 | 2004 | 80 | 0.060 |
Why?
| 14-3-3 Proteins | 1 | 2004 | 22 | 0.060 |
Why?
| Blood Cell Count | 1 | 2004 | 43 | 0.060 |
Why?
| CHO Cells | 3 | 2016 | 125 | 0.060 |
Why?
| Osteoclasts | 1 | 2008 | 472 | 0.060 |
Why?
| Mice, Inbred BALB C | 2 | 2018 | 368 | 0.060 |
Why?
| Fluorescent Antibody Technique | 1 | 2004 | 141 | 0.060 |
Why?
| Microscopy, Electron, Transmission | 1 | 2004 | 87 | 0.060 |
Why?
| Receptors, Thrombin | 2 | 2014 | 15 | 0.060 |
Why?
| Receptors, Cell Surface | 1 | 2004 | 133 | 0.060 |
Why?
| Interleukin-1 | 2 | 2017 | 109 | 0.060 |
Why?
| Crotalid Venoms | 1 | 2003 | 12 | 0.060 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 176 | 0.060 |
Why?
| Proto-Oncogene Proteins | 1 | 2004 | 163 | 0.060 |
Why?
| Cell Division | 1 | 2004 | 330 | 0.060 |
Why?
| Melanoma | 1 | 2007 | 315 | 0.060 |
Why?
| Saccharomyces cerevisiae | 1 | 2004 | 215 | 0.060 |
Why?
| Mutagenesis | 1 | 2003 | 77 | 0.060 |
Why?
| Adenosine | 1 | 2023 | 71 | 0.050 |
Why?
| Ticlopidine | 1 | 2023 | 56 | 0.050 |
Why?
| Terminology as Topic | 1 | 2002 | 71 | 0.050 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2002 | 47 | 0.050 |
Why?
| In Situ Hybridization | 1 | 2002 | 85 | 0.050 |
Why?
| Middle Aged | 4 | 2023 | 13094 | 0.050 |
Why?
| Neurotransmitter Agents | 1 | 2002 | 38 | 0.050 |
Why?
| Sequence Homology, Amino Acid | 1 | 2002 | 183 | 0.050 |
Why?
| Fibroblasts | 2 | 2017 | 386 | 0.050 |
Why?
| Synapses | 1 | 2002 | 89 | 0.050 |
Why?
| Phospholipase C gamma | 1 | 2020 | 4 | 0.050 |
Why?
| Transgenes | 2 | 2014 | 55 | 0.050 |
Why?
| Meninges | 1 | 2020 | 13 | 0.050 |
Why?
| Integrin beta3 | 2 | 2011 | 6 | 0.050 |
Why?
| RNA, Messenger | 1 | 2004 | 1222 | 0.050 |
Why?
| E-Selectin | 1 | 2019 | 19 | 0.050 |
Why?
| Intention to Treat Analysis | 1 | 2019 | 28 | 0.050 |
Why?
| Receptors, G-Protein-Coupled | 2 | 2013 | 55 | 0.050 |
Why?
| Arachidonic Acid | 1 | 2019 | 39 | 0.050 |
Why?
| Up-Regulation | 1 | 2002 | 514 | 0.050 |
Why?
| Placebos | 1 | 2019 | 92 | 0.050 |
Why?
| Kupffer Cells | 1 | 2019 | 18 | 0.040 |
Why?
| Glomerular Filtration Rate | 1 | 2019 | 138 | 0.040 |
Why?
| Asia, Southeastern | 1 | 2019 | 12 | 0.040 |
Why?
| Endothelium | 1 | 2019 | 45 | 0.040 |
Why?
| Cytoplasmic Granules | 1 | 2019 | 24 | 0.040 |
Why?
| Hyaluronic Acid | 1 | 2019 | 32 | 0.040 |
Why?
| Peroxidase | 1 | 2018 | 20 | 0.040 |
Why?
| N-Acetylneuraminic Acid | 1 | 2018 | 16 | 0.040 |
Why?
| Pancreatic Elastase | 1 | 2018 | 15 | 0.040 |
Why?
| Bacteriocins | 1 | 2018 | 1 | 0.040 |
Why?
| Phosphatidylethanolamines | 1 | 2018 | 13 | 0.040 |
Why?
| Factor Xa | 1 | 2018 | 7 | 0.040 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2018 | 93 | 0.040 |
Why?
| Protein Unfolding | 1 | 2017 | 5 | 0.040 |
Why?
| Glycosylation | 1 | 2018 | 114 | 0.040 |
Why?
| Shear Strength | 1 | 2017 | 11 | 0.040 |
Why?
| Transfection | 3 | 2004 | 410 | 0.040 |
Why?
| Binding, Competitive | 1 | 2017 | 118 | 0.040 |
Why?
| Double-Blind Method | 1 | 2019 | 747 | 0.040 |
Why?
| Cell Polarity | 1 | 2017 | 19 | 0.040 |
Why?
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2017 | 4 | 0.040 |
Why?
| Drug Design | 1 | 2018 | 136 | 0.040 |
Why?
| Adenosine Diphosphate | 1 | 2016 | 23 | 0.040 |
Why?
| Blood Coagulation Tests | 1 | 2016 | 24 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2018 | 130 | 0.040 |
Why?
| Protein Processing, Post-Translational | 1 | 2018 | 178 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2018 | 143 | 0.040 |
Why?
| Survival Analysis | 1 | 2019 | 739 | 0.040 |
Why?
| Mast Cells | 1 | 2017 | 67 | 0.040 |
Why?
| Skin | 1 | 2020 | 469 | 0.040 |
Why?
| Cell Degranulation | 1 | 2016 | 4 | 0.040 |
Why?
| Fibrinolytic Agents | 1 | 2018 | 139 | 0.040 |
Why?
| Receptors, Purinergic P2Y12 | 2 | 2009 | 12 | 0.040 |
Why?
| Blood Component Removal | 1 | 2016 | 18 | 0.040 |
Why?
| Body Weight | 1 | 2019 | 583 | 0.040 |
Why?
| Immunoglobulin G | 1 | 2017 | 228 | 0.040 |
Why?
| Cricetulus | 1 | 2016 | 103 | 0.040 |
Why?
| Calcium-Binding Proteins | 1 | 2016 | 61 | 0.040 |
Why?
| Gryllidae | 2 | 1986 | 2 | 0.040 |
Why?
| Orthoptera | 2 | 1986 | 2 | 0.040 |
Why?
| DNA, Ribosomal | 2 | 1986 | 27 | 0.040 |
Why?
| Mice, SCID | 1 | 2016 | 196 | 0.030 |
Why?
| Apolipoproteins E | 1 | 2016 | 63 | 0.030 |
Why?
| Protein Multimerization | 1 | 2016 | 54 | 0.030 |
Why?
| Brain | 1 | 2004 | 1364 | 0.030 |
Why?
| Kinetics | 1 | 2016 | 693 | 0.030 |
Why?
| Endothelial Cells | 1 | 2017 | 296 | 0.030 |
Why?
| Gene Transfer Techniques | 1 | 2014 | 41 | 0.030 |
Why?
| Immune System | 1 | 2014 | 49 | 0.030 |
Why?
| Tyrosine | 2 | 2006 | 137 | 0.030 |
Why?
| Hydroxylation | 1 | 2013 | 61 | 0.030 |
Why?
| Base Sequence | 3 | 2003 | 732 | 0.030 |
Why?
| Cell Adhesion | 2 | 2006 | 171 | 0.030 |
Why?
| Chemotaxis, Leukocyte | 1 | 2013 | 20 | 0.030 |
Why?
| Cattle | 1 | 2013 | 224 | 0.030 |
Why?
| Proteolysis | 1 | 2013 | 102 | 0.030 |
Why?
| Adoptive Transfer | 1 | 2013 | 37 | 0.030 |
Why?
| Ferric Compounds | 1 | 2012 | 14 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2013 | 199 | 0.030 |
Why?
| Cricetinae | 2 | 2003 | 211 | 0.030 |
Why?
| Immunosuppressive Agents | 1 | 2014 | 249 | 0.030 |
Why?
| Factor XII | 1 | 2012 | 2 | 0.030 |
Why?
| Mass Spectrometry | 1 | 2013 | 312 | 0.030 |
Why?
| rab4 GTP-Binding Proteins | 1 | 2012 | 8 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 209 | 0.030 |
Why?
| Prospective Studies | 1 | 2019 | 2607 | 0.030 |
Why?
| Transglutaminases | 1 | 2012 | 17 | 0.030 |
Why?
| Phosphoproteins | 1 | 2013 | 116 | 0.030 |
Why?
| Chlorides | 1 | 2012 | 58 | 0.030 |
Why?
| Binding Sites | 2 | 2003 | 443 | 0.030 |
Why?
| Blotting, Western | 1 | 2013 | 685 | 0.030 |
Why?
| Thrombocytopenia, Neonatal Alloimmune | 1 | 2011 | 1 | 0.030 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 208 | 0.030 |
Why?
| Immunoblotting | 1 | 2011 | 134 | 0.030 |
Why?
| Treatment Outcome | 1 | 2023 | 5596 | 0.030 |
Why?
| Histocompatibility Antigens Class I | 1 | 2011 | 52 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2011 | 149 | 0.020 |
Why?
| Antibodies | 1 | 2011 | 177 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2019 | 3442 | 0.020 |
Why?
| Isotonic Solutions | 1 | 2010 | 21 | 0.020 |
Why?
| Sodium Chloride | 1 | 2010 | 67 | 0.020 |
Why?
| Proline | 1 | 2009 | 31 | 0.020 |
Why?
| Arthritis | 1 | 2010 | 48 | 0.020 |
Why?
| Hematopoietic Stem Cells | 1 | 2011 | 215 | 0.020 |
Why?
| Hypersensitivity | 1 | 2010 | 82 | 0.020 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 570 | 0.020 |
Why?
| Frameshift Mutation | 1 | 2009 | 17 | 0.020 |
Why?
| Extracellular Matrix | 1 | 2010 | 114 | 0.020 |
Why?
| Blood Pressure | 1 | 2012 | 586 | 0.020 |
Why?
| Gene Expression | 1 | 2011 | 667 | 0.020 |
Why?
| Young Adult | 1 | 2019 | 4320 | 0.020 |
Why?
| Family Health | 1 | 2009 | 83 | 0.020 |
Why?
| Genes | 2 | 1986 | 38 | 0.020 |
Why?
| Dipeptides | 1 | 2008 | 20 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2009 | 218 | 0.020 |
Why?
| Protease Inhibitors | 1 | 2008 | 64 | 0.020 |
Why?
| Genome | 1 | 2007 | 74 | 0.020 |
Why?
| Arteries | 1 | 2007 | 99 | 0.020 |
Why?
| Pseudopodia | 1 | 2006 | 4 | 0.020 |
Why?
| Interleukin-4 Receptor alpha Subunit | 1 | 2006 | 4 | 0.020 |
Why?
| Models, Animal | 1 | 2007 | 255 | 0.020 |
Why?
| Arterioles | 1 | 2006 | 36 | 0.020 |
Why?
| Adult | 2 | 2019 | 14196 | 0.020 |
Why?
| Laminin | 1 | 2006 | 30 | 0.020 |
Why?
| Drug Combinations | 1 | 2006 | 129 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2006 | 159 | 0.020 |
Why?
| Proteoglycans | 1 | 2006 | 97 | 0.020 |
Why?
| Cornea | 1 | 2006 | 62 | 0.020 |
Why?
| Fibroblast Growth Factors | 1 | 2006 | 59 | 0.020 |
Why?
| Hemoglobins | 1 | 2006 | 125 | 0.020 |
Why?
| Glycoproteins | 1 | 2006 | 132 | 0.020 |
Why?
| Pyrimidines | 1 | 2006 | 196 | 0.020 |
Why?
| RNA, Ribosomal | 1 | 1985 | 18 | 0.020 |
Why?
| Aged | 1 | 2019 | 10059 | 0.020 |
Why?
| Agglutination Tests | 1 | 2004 | 5 | 0.020 |
Why?
| Models, Statistical | 1 | 2006 | 259 | 0.020 |
Why?
| Drosophila melanogaster | 1 | 2004 | 23 | 0.020 |
Why?
| Pregnancy | 1 | 2011 | 2614 | 0.020 |
Why?
| Hydrogen Bonding | 1 | 2003 | 45 | 0.010 |
Why?
| Crystallization | 1 | 2003 | 46 | 0.010 |
Why?
| DNA, Complementary | 1 | 2003 | 147 | 0.010 |
Why?
| Alprostadil | 1 | 2003 | 12 | 0.010 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 318 | 0.010 |
Why?
| Crystallography, X-Ray | 1 | 2003 | 179 | 0.010 |
Why?
| Heterozygote | 1 | 2003 | 96 | 0.010 |
Why?
| DNA Primers | 1 | 2003 | 225 | 0.010 |
Why?
| Cyclic AMP | 1 | 2003 | 114 | 0.010 |
Why?
| Alternative Splicing | 1 | 2002 | 63 | 0.010 |
Why?
| Cell Fractionation | 1 | 2002 | 18 | 0.010 |
Why?
| Macromolecular Substances | 1 | 2002 | 47 | 0.010 |
Why?
| Zinc Fingers | 1 | 2002 | 23 | 0.010 |
Why?
| Microscopy, Electron | 1 | 2002 | 97 | 0.010 |
Why?
| Dimerization | 1 | 2002 | 59 | 0.010 |
Why?
| Excitatory Postsynaptic Potentials | 1 | 2002 | 36 | 0.010 |
Why?
| Electrophysiology | 1 | 2002 | 76 | 0.010 |
Why?
| Spectrometry, Fluorescence | 1 | 2002 | 53 | 0.010 |
Why?
| Models, Molecular | 1 | 2003 | 426 | 0.010 |
Why?
| Brain Chemistry | 1 | 2002 | 74 | 0.010 |
Why?
| Phylogeny | 1 | 2002 | 269 | 0.010 |
Why?
| Fungal Proteins | 1 | 2002 | 132 | 0.010 |
Why?
| Plasmids | 1 | 2002 | 180 | 0.010 |
Why?
| Recombination, Genetic | 1 | 2002 | 108 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2004 | 925 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 2002 | 196 | 0.010 |
Why?
| Cell Movement | 1 | 2002 | 276 | 0.010 |
Why?
| Cell Line | 1 | 2004 | 1166 | 0.010 |
Why?
| Hippocampus | 1 | 2002 | 240 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2002 | 1478 | 0.010 |
Why?
| DNA Restriction Enzymes | 2 | 1986 | 16 | 0.010 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1986 | 92 | 0.010 |
Why?
| Cloning, Molecular | 2 | 1986 | 205 | 0.010 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1986 | 60 | 0.000 |
Why?
| Molecular Weight | 1 | 1985 | 104 | 0.000 |
Why?
| Transcription, Genetic | 1 | 1986 | 419 | 0.000 |
Why?
| Escherichia coli | 1 | 1985 | 249 | 0.000 |
Why?
|
|
Ware's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|